๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Pune
Clinical trial register · India

Clinical Trials in Pune

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1123 matching records held by the registry are in this view. Synced 21 Sep 2026, 03:16 UTC
1123
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 332 Mumbai 259 Hyderabad 237 Bangalore 193 Pune 189
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company13 AstraZeneca13 Novartis Pharmaceuticals12 Pfizer11 Janssen Research & Development, LLC10
Site location
New Delhi332 Mumbai259 Hyderabad237 Bangalore193 Pune189
All 274 locations
Target enrolment
to
189 of 1123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Recruiting
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
NCT07282743Type II Diabetes Mellitus
Sun Pharmaceutical Industries Limited
Phase 2
285
Guntur, Bangalore, Kozhikode, Trivandrum, Kolhฤpur, Mumbai, Pune, New Delhi
2026-01-20
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
NCT07221357Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb
Phase 2/3
990
Nashik, Thiruvananthapuram, Mumbai, Delhi, Puducherry, Pune
2025-12-31
Recruiting
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
NCT07285460Hemophilia
Sanofi
Phase 3
85
Bengaluru, Mumbai, Pune, Vellore
2025-12-18
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
NCT07282600Overweight, Obesity
Eli Lilly and Company
Phase 3
1,035
Bangalore, Belgavi, Lucknow, Nagpur, Pune, Ulhasnagar
2025-12-15
Active, closed
Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease
NCT06851806Respiratory Syncytial Virus (RSV)
AstraZeneca
Not applicable
21
Hyderabad, Jhฤnsi, Kanpur, Kolkata, Mysore, Nagpur, Pune, Vidyanagar, Hubballi
2025-12-10
By invitation
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
NCT07256392Chronic Spontaneous Urticaria
Celldex Therapeutics
Phase 3
1,370
Nagpur, Nashik, Pune
2025-11-25
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
NCT07186101Ulcerative Colitis
Eli Lilly and Company
Phase 2
252
Ahmedabad, Chennai, Coimbatore, Hubli, Hyderabad, New Delhi, Pune, Rajkot
2025-11-10
Recruiting
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
NCT06899126Non-small Cell Lung Cancer
Daiichi Sankyo
Phase 3
686
Bangalore, Bhubaneswar, Howrah, Mangalore, Pune, Surat
2025-10-24
Recruiting
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
NCT07219173Asthma
Eli Lilly and Company
Phase 2
531
Aurangabad, Bangalore, Bhubaneswar, Dwฤrka, Kanpur, New Delhi, Pune, Raipur
2025-10-22
Recruiting
Nuvastaticยฎ Phase III Trial for Fatigue in Triple-Negative Breast Cancer
NCT07669467Fatigue Related to Cancer Treatment, Breast Cancer
Natureceuticals Sdn Bhd
Phase 3
250
Visakhapatnam, Mysore, Jalgaon, Pune, Erode, Kanpur
2025-10-01
Recruiting
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastaticยฎ 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.
NCT07669454Fatigue Related to Cancer Treatment, Colon Cancer
Natureceuticals Sdn Bhd
Phase 3
250
Visakhapatnam, Mysore, Jalgaon, Pune, Erode, Kanpur
2025-10-01
Not yet open
A Mixed Methods Study on How Urban Slum Food Environments Influence Caregivers' Feeding Practices for Children Under Five Years in Pune, India
NCT07146477Feeding Practices, Food Choices, Maternal and Child Health
Hirabai Cowasji Jehangir Medical Research Institute
Observational
370
Pune
2025-09-29
Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
NCT07144280Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma
Pfizer
Phase 3
680
Mumbai, Pune, New Delhi, Kolkata, Delhi, Kerala
2025-09-29
Recruiting
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers
NCT06995482Healthy Postmenopausal Women
Kashiv BioSciences, LLC
Phase 1
40
Pune
2025-08-18
Recruiting
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
NCT07042100Advanced Solid Tumors
Sun Pharma Advanced Research Company Limited
Phase 1
177
Rohtak, Ernฤkulam, Mumbai, Pune, Delhi, Bikaner, Udaipur
2025-08-12
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
NCT07062965Breast Cancer
Pfizer
Phase 3
400
Surat, Bengaluru, Nashik, Pune
2025-08-05
Active, closed
Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India
NCT07109297RSV Immunization
Sanofi
Phase 4
110
Bengaluru, Jaipur, Kolkata, Nagpur, New Delhi, Pune, Vizianagaram
2025-07-31
Recruiting
Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India
NCT07044687Acute Myeloid Leukemia
AbbVie
Phase 4
100
Gurgaon, Bengaluru, Thiruvananthapuram, Mumbai, Pune, New Delhi, Bhubaneswar, Chennai
2025-07-24
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
NCT06758401Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer
Phase 3
714
Bengaluru, Mumbai, Pune, Thane, New Delhi, Hyderabad
2025-07-23
Active, closed
Gender-Transformative Interventions and Normative Beliefs About Reproductive Decision-Making
NCT07734961Norm, Social, Autonomy, Relation, Family
Technical University of Munich
Not applicable
2,276
Pune
2025-07-15
Not yet open
A Study to Assess the Effect Probiotic Supplement on Immune Health in Teachers Prone to Upper Respiratory Tract Infection
NCT07033754URTI - Viral Upper Respiratory Tract Infection
Vedic Lifesciences Pvt. Ltd.
Not applicable
100
Vadodara, Nashik, Pune, New Delhi, Varanasi
2025-06-25
Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
NCT06962800Primary Membranous Nephropathy
Biogen
Phase 3
180
Hyderabad, Bangalore, Pune, New Delhi, Lucknow, Varanasi, Kolkata, Chandigarh
2025-05-22
Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
NCT06890598Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company
Phase 3
700
Ahmedabad, Aurangabad, Chennai, Mumbai, Namakkal, Patna, Pune, Thalassery
2025-03-27
Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
NCT06819007Ovarian Cancer
Daiichi Sankyo
Phase 3
582
Ahmedabad, Kolkata, Mumbai, Nagpur, Nashik, Pune, Vadodara, Varanasi
2025-03-19
Recruiting
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
NCT06192160Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2
315
Pune
2025-03-11
Rows per page Showing 26–50 of 189
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/city/pune

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.